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Abstract
Increased expression of Hsp72 accompanies differentiation of human neuroblastoma SH-SY5Y cells to neuron-like cells. By
modulating cellular levels of Hsp72, we demonstrate here its anti-apoptotic activity both in undifferentiated and neuron-like
cells. Thermal preconditioning (43uC for 30 min) induced Hsp72, leading to cellular protection against apoptosis induced by
a subsequent treatment with staurosporine. Preconditioned staurosporine-treated cells displayed decreased Bax
recruitment to mitochondria and subsequent activation, as well as reduced cytochrome c redistribution from mitochondria.
The data are consistent with Hsp72 blocking apoptosis upstream of Bax recruitment to mitochondria. Neuron-like cells (with
elevated Hsp72) were more resistant to staurosporine by all measured indices of apoptotic signaling. Use of stable
transfectants ectopically expressing moderately elevated levels of Hsp72 revealed that such cells in the undifferentiated
state showed enhanced resistance to staurosporine-induced apoptosis, which was even more robust after differentiation to
neuron-like cells. Overall, the protective effects of differentiation, thermal preconditioning and ectopic Hsp72 expression
were additive. The strong inverse correlation between cellular Hsp72 levels and susceptibility to apoptosis support the
notion that Hsp72 acts as a significant neuroprotective factor, enabling post-mitotic neurons to withstand potentially lethal
stress that induces apoptosis.
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Introduction
Apoptosis in neurons contributes to pathological conditions,
such as the acute brain injury that occurs in stroke, or the chronic
injury in neurodegenerative disorders [1]. In particular, the
mitochondrial pathway of apoptosis can be elicited by cellular
stresses, including DNA damage or loss of survival-inducing
intracellular or extracellular signaling pathways [2,3]. In response
to cellular stresses, Bax is recruited to the mitochondria where it is
activated, leading to redistribution of intermembrane space
proteins such as cytochrome c (cyt c) from the mitochondria to
the cytosol [3]. Cyt c in the cytosol associates with Apaf-1 to
promote assembly of Apaf-1 into the multi-protein apoptosome
structure. The apoptosome recruits and activates procaspase-9,
which then cleaves other procaspases such as procaspase-3,
thereby initiating a caspase cascade, cleaving key cellular
substrates that generate apoptotic changes in the cell, including
characteristic changes in nuclear morphology [2].
The tendency of cells to undergo apoptosis can be modulated by
intracellular factors, some of which are induced as a result of mild
stress. For example, Hsp72 is often induced during cellular stress
to repair damage, maintain cellular homeostasis and facilitate the
recovery of cells from otherwise lethal stimuli [4,5]. Thus, Hsp72 is
upregulated in injured and damaged areas of the brain during a
variety of external stresses such as hyperthermia, stroke, ischemia
and acute brain injury [6]. At a cellular level, Hsp72 is upregulated
in neuronal cells under thermal preconditioning, a non-lethal
thermal stress that protects cells from a subsequent, otherwise
lethal, cellular insult [7,8,9,10,11].
Recent evidence supports the notion that Hsp72 is able to
protect cells from lethal stresses by its ability to specifically block
apoptotic pathways in cells upstream of mitochondria [12,13],
despite earlier claims to the contrary [14,15]. We have shown that
increased expression of Hsp72 accompanies the differentiation of
human neuroblastoma SH-SY5Y cells, driven by retinoic acid and
brain derived neurotrophic factor, to neuron-like cells [11]. Using
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24473hyperthermic stress as a cellular insult, we demonstrated that
Hsp72 has a major role in the enhanced hyperthermic resistance
acquired during neuronal differentiation of SH-SY5Y cells [11].
Recognizing that hyperthermic cell death is often manifested as
apoptotic death [16,17], although severe or prolonged heat
treatments induce necrosis [11,18], we reasoned that it would be
important to apply a specific apoptosis inducer to determine in
more detail the mechanism by which Hsp72 blocks death in this
neuronal system. Accordingly, we selected the kinase inhibitor
staurosporine [19], in light of its well-known ability to induce
apoptosis [20,21,22].
In this report, we used SH-SY5Y cells to study the protective
effects of neuronal differentiation, induction of thermotolerance
(through thermal preconditioning), and ectopic expression of
Hsp72, on apoptotic signaling induced by STS. Our results
establish a strong relationship between the resistance to STS-
induced apoptosis in SH-SY5Y cells and the level of Hsp72. The
data indicate that the protective effects of Hsp72 lie upstream of
mitochondrial engagement in apoptotic signaling.
Results
Apoptotic nuclear fragmentation is reduced in thermally
preconditioned SH-SY5Y cells in response to STS
treatment
Applying a Cell Titer-Blue cell viability assay, undifferentiated
SH-SY5Y cells subjected to thermal preconditioning showed
modest protection against death induced by 50 nM STS for 12 h,
whereas neuron-like SH-SY5Y cells similarly treated with 50 nM
STS show significantly greater cell survival when thermally
preconditioned (p,0.01) (Figure 1A). Higher concentrations of
STS tend to kill cells regardless of differentiation or thermal
preconditioning (data not shown).
Induction of apoptosis in SH-SY5Y cells by STS was indicated
by characteristic changes in nuclear morphology (Figure 1B). In
contrast to nuclei in untreated cells, chromatin in apoptotic nuclei
is typically condensed and fragmented. Following a 12-h exposure
to STS (50 nM), undifferentiated SH-SY5Y cells showed about
20% apoptotic cells (p,0.0001), while neuron-like cells showed a
significantly smaller induction of apoptosis, about 15% (p,0.001)
(Figure 1C). As observed in previous studies in our laboratory [11],
SH-SY5Y cells differentiated with RA and BDNF were found to
express increased levels of Hsp72 compared to undifferentiated
SH-SY5Y cells (Figure 2A and B, lanes 1 and 3). The resistance to
STS treatment in neuron-like SH-SY5Y cells is consistent with the
upregulation of Hsp72 upon differentiation. Acquisition of such
resistance to STS-induced death, comparing neuron-like and
undifferentiated SH-SY5Y cells, is not reflected in the Cell Titer-
Blue assays (Figure 1A). This is because of the relatively low
sensitivity of this gross metabolic assessment, nonetheless useful to
determine an appropriate concentration of STS for the present
studies.
In the case of SH-SY5Y cells that were thermally precondi-
tioned to upregulate Hsp72 and subsequently treated with STS,
both undifferentiated and neuron-like SH-SY5Y are significantly
protected from STS as measured by nuclear fragmentation
(p,0.01, in each case) (Figure 1C). Thus, in preconditioned
undifferentiated cells, preconditioning reduced apoptosis to 15%,
while neuron-like SH-SY5Y cells are almost completely
protected. These findings are in accord with the upregulation
of Hsp72 by thermal preconditioning, in each case elevating the
levels of Hsp72 above the base level in the respective cells
(Figure 2).
The redistribution of cytochrome c from mitochondria in
response to STS is reduced in thermally preconditioned
SH-SY5Y cells
To establish more precisely where Hsp72 may act to effect the
apoptotic block, steps in the mitochondrial pathway to apoptosis
were examined. Subsequent to thermal preconditioning, undiffer-
entiated and neuron-like SH-SY5Y cells were treated with STS.
Cells were harvested, fixed and immunostained using mouse anti-
cyt c antibody, and also exposed to DAPI (49,6-diamidino-2-
phenylindole) to stain the nuclei (Figure 3A). Images of control
cells show that cyt c colocalizes with Hsp60 in mitochondria. After
STS treatment, cyt c in many cells redistributes to the cytosol and
often can be visualized to lie over the nuclear region [21,23], the
latter indicated by DAPI staining to be apoptotic in morphology
Figure 1. Thermal preconditioning protects SH-SY5Y cells from
cell death and nuclear fragmentation induced by STS. (A) SH-
SY5Y cells, undifferentiated (U) or neuron-like (N), were either kept at
37uC (black bars) or thermally preconditioned (striped bars) prior to
treatment for 12 h with STS (50 nM). Cells were harvested and a cell
viability assay (Cell Titer-Blue) was carried out. (B) Images of DAPI-
stained undifferentiated SH-SY5Y cells. Arrows indicate fragmented
apoptotic nuclei. Similar images were obtained with neuron-like SH-
SY5Y cells (data not shown). Bar=10 mm. (C) Nuclear fragmentation was
quantified in SH-SY5Y cells, undifferentiated (U) or neuron-like (N), each
treated with 50 nM STS for 12 h with (striped bars) or without (black
bars) thermal preconditioning. For data in panels A and C, at least 300
cells were scored for each of three independent experiments; error bars
indicate standard deviation. *p,0.05; **p,0.01; ***p,0.0001.
doi:10.1371/journal.pone.0024473.g001
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location of mitochondria (typically pyknotic in these apoptotic
cells), clustered around the nucleus [24].
Quantified data (Figure 3B) show that 28% of undifferentiated
SH-SY5Y cells in the absence of thermal preconditioning have
undergone cyt c redistribution in response to STS, with a
markedly reduced proportion in neuron-like SH-SY5Y cells
(14%, p,0.0001). Subsequent to thermal preconditioning, both
undifferentiated and differentiated SH-SY5Y cells are protected to
a significant degree (p,0.01) relative to their non-preconditioned
counterparts. These results indicate that the putative apoptotic
block effected by Hsp72 is upstream of cyt c release from
mitochondria.
The activation of Bax at the mitochondria and
recruitment of Bax to mitochondria in response to STS
are reduced in thermally preconditioned SH-SY5Y cells
Recruitment of Bax to mitochondria and its activation on the
outer membrane are required for outer membrane permeabiliza-
tion leading to cyt c redistribution. The conformationally active
state of Bax in thermally preconditioned and STS-treated SH-
SY5Y cells was investigated, using an antibody that specifically
recognizes an epitope of Bax that is exposed only when it has been
activated [25]. This was achieved by using CHAPS buffer for
antibody permeation into fixed cells, as described previously [25].
Undifferentiated SH-SY5Y control cells (Figure 4A, top row)
fail to show activated Bax, as expected. Similar images were
obtained for neuron-like SH-SH5Y cells (data not shown). These
untreated cells clearly show many mitochondria by Hsp60 staining
and display normal nuclei by DAPI staining. Amongst cells treated
with STS (Figure 4A, bottom row) some show Bax activated at the
mitochondria, the punctate pattern of activated Bax colocalizing
with Hsp60. These cells also display apoptotic nuclei (inset).
Quantified data (Figure 4B) reveal a significantly reduced extent
(p,0.001) of Bax activation (13%) occurring in neuron-like SH-
SY5Y cells treated with STS compared to their undifferentiated
counterparts (30%). With thermal preconditioning, undifferenti-
ated and neuron-like SH-SY5Y cells are both protected against
Bax activation. This protection is more extensive in neuron-like
SH-SY5Y cells relative to their undifferentiated counterparts. As
above, protective effects of differentiation and thermal precondi-
tioning are additive.
In confirmation of this study on Bax activation, Bax recruitment
to the mitochondria was monitored in thermally preconditioned
SH-SY5Y cells treated with STS. Fixed cells were permeabilized
with Triton-X-100 (as opposed to CHAPS buffer) and immuno-
stained by rabbit anti-Bax antibodies, allowing the detection of
both non-active and activated Bax.
In untreated cells (Figure 4C, top row), Bax shows diffuse
staining throughout the cells, quite distinct from mitochondria
(identified by Hsp60 staining). In contrast, some STS-treated cells
have recruited Bax to mitochondria (Figure 4C, bottom row), the
Bax staining colocalizing with that of Hsp60. In such cells, nuclei
are typically apoptotic (inset).
Quantified data (Figure 4D) indicate reduced Bax recruitment
(p,0.0001) occurring in neuron-like SH-SY5Y cells (11%) treated
with STS, compared to their undifferentiated counterparts (25%),
as for Bax activation (Figure 4B). Likewise, after thermal
preconditioning, both undifferentiated and neuron-like SH-
SY5Y cells show enhanced deficits in Bax recruitment, the latter
more so. Collectively, these data on mitochondrial indicators of
apoptosis clearly indicate that the apoptotic block by Hsp72 is
upstream of Bax recruitment to mitochondria.
Apoptotic signaling is blocked upstream of mitochondria
in cells over-expressing Hsp72
To demonstrate more directly the requirement for Hsp72 in
achieving protection against apoptotic signaling induced by STS,
stably transfected 5YHSP72.1 cells with moderately elevated
Hsp72 levels, within the physiological range (Figure 2A and B,
Lane 5), were assessed. SH-SY5Y and 5YHSP72.1 cells were each
treated with STS for 12 h and monitored for apoptotic markers,
namely, nuclear fragmentation and Bax activation (the latter is
more clearly visualized than Bax recruitment, cf. Figure 4A and
C).
Undifferentiated 5YHSP72.1 cells are protected against the
apoptotic effects of STS treatment compared to undifferentiated
SH-SY5Y cells, as assessed by both nuclear fragmentation
(Figure 5A) and Bax activation (Figure 5B). Thus, whereas
undifferentiated SH-SY5Y cells show about 25–30% of cells with
either of these two apoptotic markers, after STS treatment, the
stably transfected undifferentiated 5YHSP72.1 cells show signifi-
cantly reduced extents of apoptosis (about 10% for each marker;
p,0.001). Moreover, neuron-like 5YHSP72.1 cells showed an
almost complete deficit in Bax activation and nuclear fragmenta-
Figure 2. Hsp72 expression levels of SH-SY5Y and 5YHSP72.1
cells. (A) SH-SY5Y and 5YHSP72.1 cells were cultured in the
undifferentiated form (RA/BDNF 2) or differentiated with RA and BDNF
(RA/BDNF +). Cells were then either kept at 37uC or thermally
preconditioned (PC) at 43uC for 30 min, followed by a recovery period
of 8 h at 37uC before harvesting. Cell lysates were collected and
subjected to Western immunoblotting with anti-Hsp72 and actin
antibodies. (B) Levels of Hsp72 induction were quantified by
densitometric analysis of the type of image shown in panel A and in
ref. [11]. Data in Panel B were adapted from those shown in ref. [11],
with permission from the publisher. * Fold induction values from all
densitometric analyses here were normalised to the levels of Hsp72 in
undifferentiated SH-SY5Y cells. All results are from three independent
experiments. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0024473.g002
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basal levels seen in untreated cells.
Thermally preconditioned undifferentiated 5YHSP72.1 cells
displayed significant induction levels of Hsp72 (Figure 2A and B,
Lane 6) and further suppressed STS-induced apoptosis, indicated
by criteria of both nuclear fragmentation (Figure 5A) and Bax
activation (Figure 5B) (p,0.01). Thermal preconditioning had
little demonstrable further effect on neuron-like 5YHSP72.1 cells,
as they already showed almost a complete deficit of Bax activation
and nuclear fragmentation.
Pharmacological inhibition of Hsp72 by KNK437 restores
susceptibility of cells to STS-induced apoptosis
To strengthen the proposal that Hsp72 can suppress mitochondrial
apoptotic signalling induced by STS, ablation of Hsp72 would be a
desirable approach. However, since siRNA approaches to achieve
knockdown of Hsp72 were unsuccessful (data not shown), pharmaco-
logical blockade of Hsp72 synthesis was applied by use of KNK437 (N-
formyl-3,4-methylenedioxy-benzylidene-c-butyrolactam). This com-
pound was shown previously to abrogate the acquisition of thermo-
tolerance in SH-SY5Y and 5YHSP72.1 cells [11].
Undifferentiated SH-SY5Y and 5YHSP72.1 cells were exposed
to KNK437 (50 mM and 75 mM, respectively) for 1 h prior to
thermal preconditioning, followed by treatment with 50 nM STS
for a further 12 h. The concentrations of KNK437 used here for
both cell types were found previously to inhibit Hsp72 induction in
thermally preconditioned cells to untreated control levels of Hsp72
[11]. Control experiments without either thermal preconditioning
or STS but in the presence of KNK437, showed that by itself this
drug did not cause significant toxicity in either undifferentiated
SH-SY5Y or 5YHSP72.1 cells, as assessed by nuclear fragmen-
tation (Figure 6A) or Bax activation (Figure 6B).
In STS-treated undifferentiated SH-SY5Y cells (not subjected to
thermal preconditioning), the addition of KNK437 does not
significantly alter the extent of apoptosis, relative to cells treated
with STS alone (Figure 6A and 6B). However, 5YHSP72.1 cells
(with no thermal preconditioning) treated with STS in the
presence of KNK437 displayed a significant increase in nuclear
fragmentation (p,0.05) and notable increases of Bax activation
(p=0.08) (about 25% for both markers) compared to 5YHSP72.1
cells treated with STS alone (about 15% for both markers). The
results indicate that ongoing synthesis of Hsp72 driven by the
Figure 3. Thermal preconditioning blocks STS-induced redistribution of cyt c from the mitochondria. (A) Images of undifferentiated SH-
SY5Y cells treated without (2) or with (+) STS (50 nM for 12 h). Cells were immunostained for cyt c (Alexa 488 labeled, green channel) and Hsp60
(Alexa 568 labeled, red channel). The same fields stained with DAPI are shown (inset shows fragmented nuclei in grayscale for clearer visibility). Merge
of first three images is shown in the far right panels. Similar images were obtained for neuron-like SH-SY5Y cells (data not shown). Bar=10 mm. (B)
Quantified data for cells displaying cyt c redistribution from the mitochondria in undifferentiated (U) and neuron-like (N) cells before (black bars) and
after (striped bars) thermal preconditioning. At least 300 cells were scored for each of three independent experiments; error bars indicate standard
deviation. *p,0.05; **p,0.01; ***p,0.0001.
doi:10.1371/journal.pone.0024473.g003
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needed for cellular protection against STS.
Significantly, in the cells exposed to thermal preconditioning,
KNK437 completely abrogates the resistance to STS-induced
apoptosis for both SH-SY5Y and 5YHSP72.1 cells. Thus, the
apoptotic indices of nuclear fragmentation (Figure 6A) and Bax
activation (Figure 6B) are both restored to the levels seen in control
undifferentiated cells treated with STS. This loss of protection can
be explained by the inhibition of Hsp72 synthesis effected by
KNK437, with consequent loss of protection of cells against
apoptotic death induced by STS.
Inverse correlation between cellular Hsp72 levels and
susceptibility to apoptosis
Based on the results described above for cellular protection
against STS mediated by neuronal cell differentiation and thermal
preconditioning, it is possible to directly correlate such protection
with cellular Hsp72 levels in Figure 2. The data integrating these
two factors are collated in Table 1, segregated into undifferenti-
ated and neuron-like cells, for convenience of presentation. Data
Figure 4. Thermal preconditioning blocks STS-induced Bax
activation and Bax recruitment at mitochondria. (A) Images of
undifferentiated SH-SY5Y cells before (2) or after (+) STS treatment
(50 nM for 12 h). Cells were immunostained for activated Bax (Alexa 488
labeled, green channel) and Hsp60 (Alexa 568 labeled, red channel). The
same fields stained with DAPI are shown (inset shows fragmented
nuclei in grayscale for clearer visibility). Merge of first three images is
shown in the far right panels. Similar images were obtained for neuron-
like SH-SY5Y cells (data not shown). Bar=10 mm. (B) Quantified data for
cells displaying activated Bax at the mitochondria in undifferentiated
(U) and neuron-like (N) cells. At least 300 cells were scored for each of
three independent experiments; error bars indicate standard deviation.
*p,0.05; **p,0.01; ***p,0.0001. (C) Images of undifferentiated SH-
SY5Y cells treated without (2) or with (+) STS (50 nM for 12 h). Cells
were immunostained for Bax distribution (Alexa 488 labeled, green
channel) and Hsp60 (Alexa 568 labeled, red channel). Other indications
are as for Panel A. (D) Quantified data for cells displaying Bax recruited
Figure 5. Ectopic expression of Hsp72 confers resistance to
apoptosis induced by STS. SH-SY5Y cells (Hsp72-Vector 2) were
compared to 5YHSP72.1 cells (Hsp72-Vector +), in each case either
undifferentiated (U) or neuron-like (N). Control cells (black bars) were
kept at 37uC while other cells were treated with STS (50 nM for 12 h),
either without (striped bars) or with prior thermal preconditioning
(white bars). Quantified data are shown for nuclear fragmentation (A)
and Bax activation (B). At least 300 cells were scored for each of three
independent experiments; error bars indicate standard deviation.
**p,0.01; ***p,0.0001.
doi:10.1371/journal.pone.0024473.g005
to the mitochondria in undifferentiated (U) and neuron-like (N) cells. At
least 300 cells were scored for each of three independent experiments;
error bars indicate standard deviation. *p,0.05; **p,0.01; ***p,0.0001.
doi:10.1371/journal.pone.0024473.g004
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Table 1, as the data are essentially redundant due to the
demonstrated pharmacological block on both cell death
(Figure 6) and Hsp72 induction [11] in the relevant undifferen-
tiated cells. Taking all these data together, there is a strong inverse
correlation between cellular levels of Hsp72 in SH-SY5Y cells and
the susceptibility to apoptotic induction. Thus, applying Spear-
man’s rank correlation analysis, r=20.72, p=0.03, results in a
significant negative correlation between these two features. A
reasonable conclusion from these correlations is that, in general,
the susceptibility to STS-induced apoptosis in SH-SY5Y cells is
determined by the cellular abundance of Hsp72.
Discussion
The anti-apoptotic function of Hsp72
We have shown in our studies using the SH-SY5Y cell model
that upon differentiation, neuron-like SH-SY5Y cells express and
induce increased levels of Hsp72 compared to their undifferenti-
ated proliferative form. The results presented here have shown
that, in general, the greater the cellular levels of Hsp72 in SH-
SY5Y cells subjected to various manipulations, the less is the
susceptibility of cells to apoptotic induction by STS.
We explicitly show here that the block in apoptosis engendered
by Hsp72 was upstream of mitochondrial engagement in apoptotic
signalling, encompassing Bax recruitment and activation, and
subsequent redistribution of cyt c. Such findings on SH-SY5Y cells
analyzed here are in conformity with those in other non-neuronal
cells types, including mouse embryo fibroblasts, human acute
lymphoblastic T-cells and COS-7 cells where Hsp72 was
found to block apoptotic signalling upstream of mitochondria
[12,26,27,28]. The results are consistent with findings in other cell
lines [29,30] where thermal preconditioning blocked subsequent
mitochondrial engagement in apoptotic signalling although, in
contrast to the present work, explicit involvement of Hsp72 was
not demonstrated. Here we have used a variety of configurations
of SH-SY5Y cells to demonstrate the ability of Hsp72 to block
mitochondrial participation in apoptosis using this neuronal cell
system.
In Table 1 it can be seen that neuronally differentiated
5YHSP72.1 cells show little induction of Hsp72 after thermal
preconditioning and the corresponding apoptotic indices (after
STS treatment) are close to the lower limit of detection.
Nonetheless, comparing 5YHSP72.1 cells, either undifferentiated
or neuron-like (without thermal preconditioning), each display
cellular levels of Hsp72 4.5-fold increased over the control
undifferentiated SH-SY5Y cells, but with significantly different
susceptibilities to apoptotic induction by STS (apoptotic indices 11
and 3.5, respectively; Table 1). Note that the neuron-like
5YHSP72.1 cells seem to have acquired resistance to apoptosis
above that reasonably ascribed to Hsp72. Therefore, there may be
factors other than Hsp72 that are evident in differentiated
5YHSP72.1 neuron-like cells that affect apoptotic susceptibility.
It is possible that the Hsp72 levels observed in thermally
preconditioned neuron-like 5YHSP72.1 cells are sufficient to block
STS-induced apoptosis. On the other hand, these neuron-like
5YHSP72.1 cells are highly susceptible to severe heat challenges at
48uC [11] as well as severe hypoxic stress with glucose deprivation
(L. Cheng and P. Nagley, unpublished observations). These severe
insults cause very rapid cell death, indicating a unregulated
necrotic-type death [31]. Hence, the resistance to STS-induced
apoptosis observed in neuron-like 5YHSP72.1 cells suggests that
Hsp72 may exclusively block mitochondrial regulated apoptotic
cell death, with little effect on unregulated necrosis.
Our data do not formally eliminate the possibility of other
possible downstream signalling events that could be blocked by
Hsp72. Potential upstream targets for Hsp72-modulated apoptotic
signalling include prosurvival members of the Bcl-2 family, such as
Mcl-1 [32], in which case Hsp72 could be considered as an
activator. It is not yet clear if proapoptotic BH3-only proteins,
required for activation of Bax or Bak on mitochondria (prior to
permeabilization of the outer mitochondrial membrane that
facilitates redistribution of cyt c), are targets for Hsp72. In this
case Hsp72 would need to be an inhibitor, to arrest apoptotic
signalling upstream of mitochondria. Other potential targets for
Hsp72 include blockade of stress signalling, including JNK,
p38MAPK and p53, all of which may impact on cells in the
intrinsic apoptosis pathway [13,33,34]. Whilst the correlation
between Hsp72 levels and resistance to apoptotic death is strong
(Table 1), our data do not eliminate the possibility that there may
be other cytoprotective factors at play.
Interestingly, the increased basal expression and induction of
Hsp72 observed in neuron-like SH-SY5Y cells is contrary to the
situation of rat pheochromocytoma PC-12 cells differentiated with
nerve growth factor which not only showed reduced levels of
Hsp72 but also failed to induce Hsp72 upon heat treatment at
42uC for 30 min and 1 h [35]. Presumably, the regulation of
Hsp72 in these neural model cells differs from that in SH-SY5Y
cells.
Figure 6. KNK437 abrogates the resistance to STS-induced
apoptosis in SH-SY5Y and 5YHSP72.1 cells. SH-SY5Y cells (black
bars) and 5YHSP72.1 (striped bars) were thermally preconditioned (PC)
or not, 8 h before treatment with 50 nM STS for a further 12 h. Where
indicated, KNK437 was added to undifferentiated SH-SY5Y cells (50 mM)
or 5YHSP72.1 cells (75 mM) 1 h before thermal preconditioning.
Quantified data are shown for nuclear fragmentation (A) and Bax
activation (B). At least 300 cells were scored for each of three
independent experiments; error bars indicate standard deviation.
*p,0.05; **p,0.01; ***p,0.0001.
doi:10.1371/journal.pone.0024473.g006
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protection against STS, thermally preconditioned undifferentiat-
ed SH-SY5Y and 5YHSP72.1 cells became highly susceptible to
apoptosis in the presence of KNK437 and STS. KNK437 is a
benzylidene lactam compound reported to inhibit thermotoler-
ance by blocking the upregulation of inducible Hsp72 [36,37,38].
KNK437 has been found to be more effective at inhibiting the
inducible Hsp72 protein compared to the broad spectrum heat
shock inhibitor quercetin [36,37]. It has been shown that
KNK437 functions by blocking the induction of Hsp70 at the
mRNA level [38]. Therefore, it is possible that KNK437 inhibits
other heat shock proteins which involve the activation of heat
shock factor 1. This drug has also been reported to inhibit
expression of Hsp105 and Hsp40 [37]. Further details of how
KNK437 functions needs to be investigated in future studies.
Nonetheless, we have shown that at non-toxic concentrations,
KNK437 effectively restricts inducible Hsp72 expression to
control (intrinsic) levels in our cell model [11]. In spite of possible
off-target effects, the data obtained using KNK437 are consistent
with Hsp72 being an important factor in both neuronal heat
resistance and protection against apoptosis.
Roles of Hsp72 in pathological context
Hsp72 has been found to be induced in a variety of
pathological states, including cerebral ischemia and neurodegen-
erative diseases, such as Alzheimer’s disease [1,39,40]. In
experimental mouse models, the expression of Hsp72 is
upregulated in the brain several hours after cerebral insult and
has been correlated with better recovery [6,41]. In cases of a
severe ischemic attack, there is a relatively small induction of
Hsp72 in the affected area. Hence, the outcome and amount of
injury to the area seems to correlate with the expression of Hsp72
detected in the region. Preconditioning has also been used widely
in several studies to induce Hsp72 and protect against a
subsequent hypoxic insult [30,42,43].
In Alzheimer’s disease, where the accumulation of misfolded
proteins is the major cause of this neurodegenerative disorder, the
increased expression of Hsp72 rescues neurons from the toxic
effects of intracellular beta-amyloid 42 (Abeta42) accumulations
[44,45]. Moreover, in an ALS model, Hsp72 upregulation protects
NSC34 cells against apoptosis associated with the presence of
mutant SOD1 aggregates, yet does not affect the frequency of
aggregate formation (K.Y Soo and P. Nagley, unpublished
observations). An understanding of the interplay between Hsp72
levels and cell survival demonstrated in this study, may lead to new
strategies for treatment and drug design targeting neuronal
survival. Compounds that can up-regulate Hsp72 levels can
potentially be used in the treatment of various cerebral insults and
neurodegenerative disorders to suppress excessive cell death and
allow neuronal function to be retained.
Conclusion
This study indicates that Hsp72 has a key role in protection
against apoptosis and that it acts upstream of Bax activation. The
data obtained indicate that the degree of protection to apoptotic
stress is dependent not only on the basal levels of Hsp72 but also
on the amount of Hsp72 induced in the various cellular scenarios
analyzed. This study supports the idea that if neurons express
beneficial levels of Hsp72 or are exposed to a preconditioning
treatment to induce Hsp72, they acquire neuroprotective features
that provide these post-mitotic cells with the ability to withstand
various stresses, thus enhancing their survival.
Materials and Methods
Reagents
Primary antibodies used for immunocytochemistry were rabbit
polyclonal Hsp60 from Abcam (Cambridge, USA); mouse
monoclonal Bax (clone 6A7) and mouse monoclonal cyt c (clone
6H2.B4) from BD Biosciences Pharmingen (San Jose, USA).
Fluorescent secondary antibodies for immunocytochemistry
conjugated to Alexa 488 or Alexa 568 were purchased from
Molecular Probes (Eugene, USA). Staurosporine (Sigma, USA)
was dissolved in dimethyl sulfoxide (DMSO) to a final stock
concentration of 500 mM. KNK437 (N-formyl-3,4-methylene-
dioxy-benzylidene-c-butyrolactam, EMD Biosciences Inc, USA)
was titrated to the appropriate concentration for experimental
use as previously described [11]. Note that for various
concentrations of KNK437 and STS applied, the input of
DMSO was held constant at 0.1%.
Table 1. Correlation of cellular levels of Hsp72 with susceptibility to STS-induced apoptosis.
Undifferentiated cells Treatment
PC 2 + 2 +
Hsp72-Vector 2 2 + +
Hsp72 Level 1 4.360.1 4.560.1 8.960.4
Apoptotic Index 2862.3 1161.4 1161.7 3.361.5
Neuron-like cells Treatment
PC 2 + 2 +
Hsp72-Vector 2 2 + +
Hsp72 Level 3.660.3 9.860.4 4.560.2 5.760.3
Apoptotic Index 1161.6 5.361.0 3.562.2 3.062.7
Data are shown separately for undifferentiated and neuron-like SH-SY5Y cells after the treatments indicated.
PC indicates thermal preconditioning.
Hsp72-Vector indicates ectopic expression of Hsp72 as stably transfected cells (5YHSP72.1).
Hsp72 Level indicates that measured by western immunoblotting analysis (Figure 2), normalized to undifferentiated untransfected SH-SY5Y cells (data are expressed as
the ratio relative to that control).
Apoptotic Index is the percentage of cells displaying apoptotic nuclei after treatment with STS (50 nM) for 12 h.
doi:10.1371/journal.pone.0024473.t001
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Human neuroblastoma SH-SY5Y cells (ATCC catalogue
number CRL-2266) were cultured in DMEM medium (Gibco,
USA) supplemented with 1 mM L-Glutamine, 10 mM HEPES
and 10% heat inactivated foetal calf serum (CSL Limited,
Australia) as described [11]. SH-SY5Y cells stably expressing
exogenous Hsp72 (denoted 5YHSP72.1) were generated by
transfecting pCI-neo Hsp72 [46] using the transfection reagent
LipofectAMINE PLUS (Invitrogen, USA) according to manufac-
turer instructions. Stably transfectant clones were selected and
maintained in medium containing G418 (500 mg/ml). Procedures
for neuronal differentiation were carried out as described [11].
Briefly, to differentiate SH-SY5Y and 5YHSP72.1 cells, undiffer-
entiated cells were treated with 10 mMo fall-trans retinoic acid
(Sigma-Aldrich, USA) in DMEM. After 5 days, RA and was
removed and 5 ng/ml of BDNF (Sigma-Aldrich, USA) was added
to the cells in DMEM without serum for a further 2 days. Thermal
preconditioning was performed by immersing cells in a water bath
(Memmert, Germany) at 43uC( 60.1uC) for 30 min and then
allowed to recover at 37uC for 8 h. Control cells were maintained
at 37uC throughout.
Cell Titer-Blue assays
Cells were seeded in a 24-well tissue culture plate and treated
with STS. At the end of the test exposure period, 20 ml Cell Titer-
Blue reagent (Promega, USA) was added per 100 ml media and
mixed gently for 10 sec. The cells were incubated at 37uC in the
absence of light for a sufficient time (usually 2 to 3 h) for detectable
reduction of resazurin to resorufin in the untreated cell control
samples, determined by the color change from blue to pink.
Fluorescence was immediately read with 560 nm excitation and
590 nm emission wavelengths using an automated microplate-
based multi-detection reader (BMG Fluorostar Optima; BMG
Labtech, Germany). The mean fluorescence value from control
reaction mixtures with culture medium (lacking cells) was
subtracted from fluorescence values of experimental wells.
Western immunoblotting and densitometry analysis
Western immunoblotting was carried out as previously
described [11]. Briefly, cells were collected and resuspended in
cell lysis buffer (1% Triton X-100, 4 mM EGTA, 15 mM MgSO4,
25 mM glycylglycine) for 5 min on ice. The suspension was
centrifuged at 10, 0006 g for 5 min and the supernatant was
collected. The protein concentration of each sample was
determined using a protein assay kit (BCA protein assay, Pierce,
USA). Cell lysates containing equivalent amounts of protein were
resolved on 12% SDS-PAGE gel, transferred to PVDF membrane
and probed with antibodies specific for Hsp72 (SPA 810, Stressgen
Biotechnologies, USA) and actin (Neomarkers, USA). Bands were
detected by the use of secondary antibodies conjugated to
horseradish peroxidase (GE Healthcare, Australia). The PVDF
membrane was then treated with enhanced chemilumiescence
substrate (Bio-Rad Laboratories, Australia) for 5 min. The PDVF
membrane was then exposed to hyperfilm (GE Healthcare,
Australia) to visualise the bands. The film was then scanned and
band density values were analyzed using the ImageQuant TL
densitometry program (GE Healthcare, UK).
Fixing and staining cells for imaging
Following treatment of undifferentiated and neuron-like cells
with STS, adherent cells (mostly viable) were trypsinized and
combined with detached cells (dead or dying) to recover the total
cell population for each sample. The cells were then centrifuged in
a cytospin centrifuge on coverslips coated with poly-D-lysine
(Sigma-Aldrich, USA) to collect adherent and floating cells. Cells
were immediately fixed with 4% (w/v) paraformaldehyde
(Electron Microscopy Sciences, USA) for 15 min at 37uC and
permeabilized with 0.1% Triton-X-100 (BDH Chemicals, USA)
for 10 min at room temperature. In experiments on Bax
activation, cells were permeabilized with CHAPS buffer
(150 mM NaCl, 10 mM HEPES, 1.0% CHAPS) for 10 min at
room temperature. The cells were blocked with 3.5% bovine
serum albumin (BSA) and incubated at room temperature for a
minimum of 30 min before immunostaining with the relevant
primary antibody, overnight at 4uC. The cells were rinsed three
times with phosphate-buffered saline (PBS) and exposed to the
relevant secondary antibody for 1 h at room temperature. Cells
were rinsed three times with PBS to remove excess secondary
antibody and then stained with 0.5 mg/ml DAPI for 10 min,
followed by a final rinse with PBS. The coverslips were inverted
and mounted on glass slides using permafluor (Thermo Scientific,
USA) ready for microscopic visualization by confocal laser
scanning microscopy.
Confocal laser scanning microscopy
Cells were imaged using an Olympus Fluoview 500 confocal
laser scanning microscope, equipped with a HeCd/Argon/HeNe
laser light source with peak emissions at 442, 488 and 543 nm.
Images were acquired using a 606water immersion objective lens.
Photomultiplier tube levels were set to a level at which bleed-
through effects from one channel to the other were negligible in
untreated control cells. The same photomultiplier tube settings
were then applied for their STS-treated counterpart cells. The
computer software ImageJ (National Institute of Health, USA) was
used to process images acquired from the confocal laser scanning
microscope.
Statistical tests
For analysis of quantified data for apoptotic indicators, for each
treatment, all cells within 3–4 microscopy fields were scored until a
threshold of 300 cells was reached, after which all remaining cells
in the final field were scored. Results were obtained from at least
three independent experiments and expressed as mean 6 standard
deviation. Student’s t-test was applied for appropriate compari-
sons. Correlations between susceptibility to STS-induced apoptosis
and cellular Hsp72 levels were analyzed using the Spearman’s
rank correlation coefficient (r). Calculations for statistical tests were
made using Microsoft Excel software package. For both tests, a
probability level (p),0.05 was considered significant.
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